BEIJING TONG REN TANG CHINESE MEDICBEIJING TONG REN TANG CHINESE MEDICBEIJING TONG REN TANG CHINESE MEDIC

BEIJING TONG REN TANG CHINESE MEDIC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.57 B‬HKD
0.59HKD
‪540.39 M‬HKD
‪1.52 B‬HKD
‪236.30 M‬
Beta (1Y)
0.95
Employees (FY)
798
Change (1Y)
+36 +4.72%
Revenue / Employee (1Y)
‪244.66 K‬HKD
Net income / Employee (1Y)
‪86.70 K‬HKD

About BEIJING TONG REN TANG CHINESE MEDIC


CEO
Chi Wang
Headquarters
Hong Kong
Founded
2004
ISIN
HK0000145638
FIGI
BBG004HNJ6Q0
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. It operates through the following geographical segments: Hong Kong, Mainland China and Overseas. The Hong Kong segment sells Chinese medicine and healthcare products and provides medical consultation and treatments through retail outlets, as well as wholesale in Hong Kong. The Mainland China segment engages in the wholesale of healthcare products in the Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside the Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments in other overseas countries/regions, including Macao. The company was founded in 1669 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 3613 is 7.99 HKD — it has increased by 1.40% in the past 24 hours. Watch BEIJING TONG REN TANG CHINESE MEDIC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange BEIJING TONG REN TANG CHINESE MEDIC stocks are traded under the ticker 3613.
3613 stock has fallen by −1.61% compared to the previous week, the month change is a −3.63% fall, over the last year BEIJING TONG REN TANG CHINESE MEDIC has showed a −38.35% decrease.
We've gathered analysts' opinions on BEIJING TONG REN TANG CHINESE MEDIC future price: according to them, 3613 price has a max estimate of 12.80 HKD and a min estimate of 11.30 HKD. Watch 3613 chart and read a more detailed BEIJING TONG REN TANG CHINESE MEDIC stock forecast: see what analysts think of BEIJING TONG REN TANG CHINESE MEDIC and suggest that you do with its stocks.
3613 reached its all-time high on May 29, 2018 with the price of 17.94 HKD, and its all-time low was 4.70 HKD and was reached on May 7, 2013. View more price dynamics on 3613 chart.
See other stocks reaching their highest and lowest prices.
3613 stock is 1.13% volatile and has beta coefficient of 0.95. Track BEIJING TONG REN TANG CHINESE MEDIC stock price on the chart and check out the list of the most volatile stocks — is BEIJING TONG REN TANG CHINESE MEDIC there?
Today BEIJING TONG REN TANG CHINESE MEDIC has the market capitalization of ‪6.57 B‬, it has decreased by −0.62% over the last week.
Yes, you can track BEIJING TONG REN TANG CHINESE MEDIC financials in yearly and quarterly reports right on TradingView.
BEIJING TONG REN TANG CHINESE MEDIC is going to release the next earnings report on Mar 17, 2025. Keep track of upcoming events with our Earnings Calendar.
3613 net income for the last half-year is ‪219.78 M‬ HKD, while the previous report showed ‪274.35 M‬ HKD of net income which accounts for −19.89% change. Track more BEIJING TONG REN TANG CHINESE MEDIC financial stats to get the full picture.
Yes, 3613 dividends are paid annually. The last dividend per share was 0.33 HKD. As of today, Dividend Yield (TTM)% is 4.20%. Tracking BEIJING TONG REN TANG CHINESE MEDIC dividends might help you take more informed decisions.
BEIJING TONG REN TANG CHINESE MEDIC dividend yield was 2.72% in 2023, and payout ratio reached 51.12%. The year before the numbers were 2.88% and 42.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 26, 2024, the company has 798.00 employees. See our rating of the largest employees — is BEIJING TONG REN TANG CHINESE MEDIC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BEIJING TONG REN TANG CHINESE MEDIC EBITDA is ‪629.25 M‬ HKD, and current EBITDA margin is 45.82%. See more stats in BEIJING TONG REN TANG CHINESE MEDIC financial statements.
Like other stocks, 3613 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEIJING TONG REN TANG CHINESE MEDIC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BEIJING TONG REN TANG CHINESE MEDIC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BEIJING TONG REN TANG CHINESE MEDIC stock shows the sell signal. See more of BEIJING TONG REN TANG CHINESE MEDIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.